Invention Grant
- Patent Title: Kappa selective opioid receptor antagonist
- Patent Title (中): Kappa选择性阿片受体拮抗剂
-
Application No.: US12757451Application Date: 2010-04-09
-
Publication No.: US08173695B2Publication Date: 2012-05-08
- Inventor: Nuria Diaz Buezo , David Lee McKinzie , Charles Howard Mitch , Concepcion Pedregal-Tercero
- Applicant: Nuria Diaz Buezo , David Lee McKinzie , Charles Howard Mitch , Concepcion Pedregal-Tercero
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent John C. Demeter
- Priority: EP08380012 20080122
- Main IPC: C07D207/06
- IPC: C07D207/06 ; C07D207/04 ; A61K31/4025 ; A61K31/40
Abstract:
A selective kappa opioid receptor antagonist useful for treating ethanol use disorder withdrawal and anxiety, and/or depression, or schizophrenia as independent comorbid conditions.
Public/Granted literature
- US20100197669A1 KAPPA SELECTIVE OPIOID RECEPTOR ANTAGONIST Public/Granted day:2010-08-05
Information query
